As fine-chemical companies, contract manufacturers, and pharmaceutical and biopharmaceutical companies prepare for CPhI Worldwide, take a look a recent technology and market developments. In this issue, GlaxoSmithKline employs continuous-flow chemistry for preparing a key pharma intermediate and Patheon discusses how to apply single-use technology in fill-finish operations. Also, examining ethyl cellulose aqueous dispersions for oral sustained release dosage forms. Plus, read about biotech financing trends and the outlook for contract fill–finish manufacturing.